Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Biggest M&A Announcements Of 2023 Show Deals Are Getting Bigger

Nov 15 2023

• By Joseph Haas

M&A concept — • Source: Shutterstock

Related Content

M&A Has Been Down, But EY Argues Conditions Are Right For An Uptick In 2023

Jan 09 2023

IRA Implications Will Factor Significantly In Deal Strategy In 2023

Jan 16 2023

Pfizer Pays $43bn For Seagen With Goal Of Rapidly, Globally Advancing ADCs

Mar 13 2023

2022 Deal-Making Snapshot: One Big Deal Didn’t Change The Downward Trends

Apr 21 2023

Merck Acquires Much Needed Diversification With $10.8bn Prometheus Buy

Apr 17 2023

BMS Speeds Expansion Into Neuroscience With $14bn Karuna Buy

Dec 22 2023

AbbVie Says Buying Spree Will Add R&D Heft Needed For Long-Term Growth

Dec 07 2023

AbbVie Strikes Again By Teeing Up $8.7bn Offer For Cerevel

Dec 06 2023

Biogen Buys Time For Leqembi Ramp-Up With Reata Acquisition

Jul 28 2023

Despite Pfizer/Seagen’s Splash, Deals Are Staying Small

Jul 12 2023

Eisai/Biogen’s Leqembi Will See Broadened Access To Majority Of Patients

Jul 07 2023

Slow Q3 For Biopharma M&A Boosted By Biogen/Reata

Oct 10 2023

Teva Calls In Sanofi To Turbocharge Its Place In Blockbuster TL1A Inflammation Race

Oct 04 2023

BMS Looks To Expand Its Oncology Reach With Mirati Buyout

Oct 09 2023

Podcast: How Will Greater FTC Scrutiny Affect Biopharma M&A Activity?

Oct 03 2023

CSL Makes $11.7bn Move On Vifor Pharma In Renal Disease Push

Dec 14 2021

AbbVie Spends $10bn On ImmunoGen To Improve Chances In ADC Space

Nov 30 2023

Pfizer Lays Out A Growth Plan To Offset $17bn In Coming Exclusivity Losses

Dec 13 2022

Prometheus Phase II Data For Novel TL1A Inhibitor Impresses On Efficacy

Dec 07 2022

Roche Makes Play For Bowel Disease Leadership With $7.1bn Roivant Deal

Oct 23 2023

Related Companies

Pfizer Inc.

Seagen Inc.

Amgen, Inc.

Horizon Therapeutics plc

CSL Limited

Bristol Myers Squibb Company

Mirati Therapeutics, Inc.

Roche Holding AG

Merck & Co., Inc.

Eli Lilly and Company

Novo Nordisk A/S

ImmunoGen, Inc.

Biogen, Inc.

Additional Topics

M & A Business Strategies Commercial Deals Growth Outlook 2024 BioPharmaceutical

More from 2024

More from Outlook

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window